J Carter Thompson Jr Ceejaye Peters

October 18, 2012 | Inside Counsel

With the U.S. Supreme Court holding last year in Pliva, Inc. v. Mensing that the manufacturer of a generic pharmaceutical product cannot be liable under a failure-to-warn theory, pharmaceutical plaintiffs are searching for new theories to hold nonmanufacturers liable for alleged injuries.

By J. Carter Thompson Jr., Ceejaye Peters

3 minute read